Donguibogam Evidence Bridge한국어

Atractylodes 蒼朮

Pharmaceutical nameAtractylodis Rhizoma

Evidence grade: Establishedauto-proposed · unreviewedSafety signal: Adverse-event literature existsMapping confidence: Strong correspondence

The three axes are assessed independently and are never combined into a single score.

KTKP records the origin species as Atractylodes lancea (Thunb.) DC.. It has not yet been cross-checked against the Korean Pharmacopoeia, so the identification confidence is not raised to an official code mapping. The same drug appears under 5 records as name variants. The same source species also yields 1 other separately registered drug(s) (Atractylodis Rhizoma Alba), which must not be conflated. The name most used for this taxon in current literature is Atractylodes lancea. Literature searches for this herb also cover Atractylodes chinensis — the same taxon appears under several names. The nomenclatural discussion for this herb was flagged for correction during verification; only the verified facts are shown here, with the details in docs/HERB_NAME_RESEARCH.md.

Tradition · what the text describes

탕액편

The sub-section within this volume has not been verified against the original text yet.

The KTKP traditional materia medica record (M0001178) gives the origin species as Atractylodes lancea (Thunb.) DC., the part used as 뿌리줄기, and the properties as 고신(苦辛), 무독(無毒), 신고(辛苦), 온(溫). It lists 간(肝), 비(脾), 소장(小腸), 위(胃), 폐(肺) as the channels entered. The same record cites the Donguibogam (1613) as the source for its indications.

Properties & channel entry: 고신(苦辛), 무독(無毒), 신고(辛苦), 온(溫) · 간(肝), 비(脾), 소장(小腸), 위(胃), 폐(肺)

Source species: Atractylodes lancea (Thunb.) DC. (뿌리줄기)

Read the original: Korean Medicine Classics DB ↗

Modern · documented evidence

Cholangiocarcinomaevidence for this indication

Evidence grade: Establishedauto-proposed · unreviewed
  • An A grade requires checking that the conclusions are consistent. Read the abstracts — counts alone cannot establish an A.
  • The indication was derived automatically from the Condition field of 0 registered trial(s). It reflects what is currently being studied, not a traditional use, and a curator should confirm the label is apt.

Literature

SR 1 · RCT 3 · preclinical 13

1 systematic review(s) and 3 randomized controlled trial(s) were found.

Query used

We publish the exact query behind these counts so you can reproduce them yourself.

SRC:MED AND ((TITLE_ABS:"Atractylodes lancea") OR (TITLE_ABS:"Atractylodes chinensis")) AND TITLE_ABS:"Cholangiocarcinoma"

Clinical trials

Safety

auto-proposed · unreviewed

  • 4 adverse-event or toxicity record(s) were found. This only flags that literature exists — read the abstracts to decide between "caution" and "harm confirmed".
  • 1 interaction-related record(s) are retrievable. This flags that literature exists — it is not an interaction checker (§3.4).
  • The KTKP record states the following traditional contraindication: 성(性)이 온조(溫燥)하여 음액(陰液)을 모손(耗損)하기 쉬우므로 음허내열자(陰虛內熱者)나 한다자(汗多者)는 복용을 기(忌)한다.

Adverse-event and toxicity literature

This is not a finding of harm — it lists literature that is retrievable. Read the papers to decide.

Interaction literature

This lists literature that is retrievable — it is not a judgement that an interaction exists. Read the papers to decide.

Sources